90.42
price up icon0.87%   0.78
after-market Dopo l'orario di chiusura: 90.42
loading

Nuvalent Inc Borsa (NUVL) Ultime notizie

pulisher
Oct 16, 2025

Custom strategy builders for tracking Nuvalent Inc.Portfolio Value Report & Risk Controlled Daily Trade Plans - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Regression analysis insights on Nuvalent Inc. performanceWeekly Loss Report & Risk Managed Investment Strategies - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Intraday pattern recognizer results for Nuvalent Inc.Earnings Growth Summary & Growth-Oriented Investment Plans - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Stifel initiates coverage on Nuvalent stock with Buy rating By Investing.com - Investing.com South Africa

Oct 15, 2025
pulisher
Oct 15, 2025

Stifel initiates coverage on Nuvalent stock with Buy rating - Investing.com

Oct 15, 2025
pulisher
Oct 15, 2025

Cantor Fitzgerald initiates Nuvalent stock with Overweight rating By Investing.com - Investing.com Australia

Oct 15, 2025
pulisher
Oct 15, 2025

Can trapped investors hope for a rebound in Nuvalent Inc.Portfolio Risk Summary & Fast Entry Momentum Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Forecasting Nuvalent Inc. price range with options dataWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will Nuvalent Inc. stock rally after Fed decisionsJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Cantor Fitzgerald initiates Nuvalent stock with Overweight rating - Investing.com India

Oct 15, 2025
pulisher
Oct 15, 2025

Multi asset correlation models including Nuvalent Inc.Market Performance Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Statistical indicators supporting Nuvalent Inc.’s strengthJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Nuvalent to present new data on HER2 inhibitor at cancer conference - Investing.com Nigeria

Oct 13, 2025
pulisher
Oct 13, 2025

Nuvalent to present new data on HER2 inhibitor at cancer conference By Investing.com - Investing.com South Africa

Oct 13, 2025
pulisher
Oct 13, 2025

Preclinical intracranial activity: Nuvalent’s NVL-330 to be presented at AACR‑NCI‑EORTC Oct 24 - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

How Nuvalent Inc. stock reacts to oil pricesBond Market & Entry Point Confirmation Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What moving averages say about Nuvalent Inc.Trade Exit Summary & Weekly High Potential Stock Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 32% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews

Oct 13, 2025
pulisher
Oct 11, 2025

Nuvalent To Participate In The UBS 2025 Virtual Oncology Day - Barchart.com

Oct 11, 2025
pulisher
Oct 10, 2025

Is Nuvalent Inc. stock bottoming outVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Nuvalent (NASDAQ:NUVL) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Nuvalent Inc. stock trendline breakdown2025 Valuation Update & Daily Chart Pattern Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Nuvalent Inc. showing signs of accumulationJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What MACD signals say about Nuvalent Inc.Trade Entry Report & Risk Managed Investment Strategies - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Nuvalent Inc. stock a buy before product launchesMarket Trend Review & Precise Buy Zone Tips - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

The Escalator: Eli Lilly, Nuvalent, Lumen Bioscience and more - Medical Marketing and Media

Oct 08, 2025
pulisher
Oct 08, 2025

Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year By Investing.com - Investing.com South Africa

Oct 08, 2025
pulisher
Oct 08, 2025

Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year - Investing.com

Oct 08, 2025
pulisher
Oct 06, 2025

J.P. Morgan Maintains Nuvalent(NUVL.US) With Buy Rating - 富途牛牛

Oct 06, 2025
pulisher
Oct 06, 2025

Nuvalent, Inc. (NUVL) Stock Analysis: Promising Biotech With 38% Upside Potential - DirectorsTalk Interviews

Oct 06, 2025
pulisher
Oct 05, 2025

What to expect from Nuvalent Inc. in the next 30 daysJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Nuvalent Inc. stock outperform Dow Jones index2025 Key Lessons & AI Driven Price Predictions - newser.com

Oct 05, 2025
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
Capitalizzazione:     |  Volume (24 ore):